AI-translated archive post

Seocho-gu Greeni Dermatology Clinic Checks the Effects and Possible Side Effects of Wegovy Injections

그리니 피부과 의원 · ❤️사당역 그리니피부과❤️ · December 19, 2025

Seocho-gu Greeni Dermatology Clinic Checking the Effects and Possible Side Effects of Wegovy Injections Hello, This is Seocho-gu Greeni Dermatology Clinic! Recently, as interest in...

AI translation notice

This page is an English translation of a Korean Naver Blog archive entry. For exact wording and source context, verify against the Korean archive original and the original Naver post.

Clinic: 그리니 피부과 의원

Original post date: December 19, 2025

Translated at: April 20, 2026 at 1:38 PM

Medical note: This translation does not guarantee medical accuracy or suitability for treatment decisions.

Seocho-gu Greeni Dermatology Clinic

Checking the Effects and Possible Side Effects of Wegovy Injections

Seocho-gu Greeni Dermatology Clinic Checks the Effects and Possible Side Effects of Wegovy Injections image 1

Hello,

This is Seocho-gu Greeni Dermatology Clinic!

Recently, as interest in health management and body-shape improvement has increased,

more and more people have been asking about Wegovy.

Wegovy is recognized as an injection that helps with weight control.

Let’s take a closer look at the details through a news article! Recently, as interest in weight loss has grown, inquiries about Wegovy injections have also increased. With reviews spreading mainly among celebrities and influencers, it has become known as a “diet injection,” but this medication was originally developed as a prescription drug for the treatment of metabolic diseases.

The active ingredient in Wegovy, semaglutide, was originally used as a treatment for diabetes, and as weight loss tendencies were observed, its use expanded into the field of obesity treatment. It is administered as a once-weekly subcutaneous injection, and there are reports that it may help reduce appetite and maintain feelings of fullness by acting similarly to GLP-1-related hormones.

Some clinical studies have reported cases in which consistent use over a certain period led to weight loss, but the degree of weight reduction varies greatly depending on an individual’s health condition, treatment period, and lifestyle habits. There are also reports of cases in which blood sugar and some metabolic indicators improved, but the effects do not apply equally to all patients.

Wegovy is recommended for adult patients with obesity and a BMI of 30 or higher, or for adults with a BMI of 27 or higher who also have metabolic diseases such as high blood pressure or diabetes. Its use is not appropriate for people at a normal weight or for purely cosmetic purposes. Common side effects may include nausea, abdominal discomfort, and constipation, and there have also been reported cases of rare adverse reactions related to pancreatitis or the gallbladder, so it should be used under medical supervision.

Seocho-gu Greeni Dermatology Clinic Checks the Effects and Possible Side Effects of Wegovy Injections image 2

Because this medication is self-injected, it is important to follow the basic instructions for use accurately, including refrigeration, stepwise dose adjustment, and rotating injection sites. If there are concerns about initial adverse reactions, another option is to receive the injection directly at a medical facility. However, it is difficult to maintain weight loss long term with medication alone, so lifestyle changes such as improving eating habits, regular physical activity, and sleep management are essential.

Director Kim Seong-min of Greeni Dermatology Clinic said, “Because this medication can produce different effects and responses depending on an individual’s health condition, a professional evaluation is important,” and added, “When used together with lifestyle management, safer and more lasting improvement can be expected.”

▼ Go to news article ▼

Continue browsing

Keep exploring this clinic's public source trail

Return to the source archive for more translated posts, or open the Korean clinic profile to compare other public channels.